BMY
Price
$47.01
Change
+$0.13 (+0.28%)
Updated
Aug 29, 03:51 PM (EDT)
Capitalization
95.42B
62 days until earnings call
HAWPF
Price
$10.62
Change
+$1.22 (+12.98%)
Updated
Aug 5 closing price
Capitalization
2.39B
Interact to see
Advertisement

BMY vs HAWPF

Header iconBMY vs HAWPF Comparison
Open Charts BMY vs HAWPFBanner chart's image
Bristol-Myers Squibb
Price$47.01
Change+$0.13 (+0.28%)
Volume$15.32K
Capitalization95.42B
Haw Par
Price$10.62
Change+$1.22 (+12.98%)
Volume$100
Capitalization2.39B
BMY vs HAWPF Comparison Chart in %
Loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAWPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMY vs. HAWPF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a StrongBuy and HAWPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BMY: $46.88 vs. HAWPF: $10.62)
Brand notoriety: BMY: Notable vs. HAWPF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 66% vs. HAWPF: 39%
Market capitalization -- BMY: $95.42B vs. HAWPF: $2.39B
BMY [@Pharmaceuticals: Major] is valued at $95.42B. HAWPF’s [@Pharmaceuticals: Major] market capitalization is $2.39B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green whileHAWPF’s FA Score has 0 green FA rating(s).

  • BMY’s FA Score: 1 green, 4 red.
  • HAWPF’s FA Score: 0 green, 5 red.
According to our system of comparison, HAWPF is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 6 TA indicator(s) are bullish while HAWPF’s TA Score has 3 bullish TA indicator(s).

  • BMY’s TA Score: 6 bullish, 4 bearish.
  • HAWPF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, BMY is a better buy in the short-term than HAWPF.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -3.20% price change this week, while HAWPF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.84%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +11.90%.

Reported Earning Dates

BMY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.84% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMY($95.4B) has a higher market cap than HAWPF($2.39B). BMY has higher P/E ratio than HAWPF: BMY (18.83) vs HAWPF (12.07). HAWPF YTD gains are higher at: 32.750 vs. BMY (-14.174). BMY has higher annual earnings (EBITDA): 15.1B vs. HAWPF (277M). BMY has more cash in the bank: 13.6B vs. HAWPF (3.95B). HAWPF has less debt than BMY: HAWPF (34M) vs BMY (50.9B). BMY has higher revenues than HAWPF: BMY (47.7B) vs HAWPF (253M).
BMYHAWPFBMY / HAWPF
Capitalization95.4B2.39B3,997%
EBITDA15.1B277M5,451%
Gain YTD-14.17432.750-43%
P/E Ratio18.8312.07156%
Revenue47.7B253M18,854%
Total Cash13.6B3.95B344%
Total Debt50.9B34M149,706%
FUNDAMENTALS RATINGS
BMY vs HAWPF: Fundamental Ratings
BMY
HAWPF
OUTLOOK RATING
1..100
1044
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
86
Overvalued
PROFIT vs RISK RATING
1..100
10041
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6043
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (6) in the Pharmaceuticals Major industry is significantly better than the same rating for HAWPF (86) in the null industry. This means that BMY’s stock grew significantly faster than HAWPF’s over the last 12 months.

HAWPF's Profit vs Risk Rating (41) in the null industry is somewhat better than the same rating for BMY (100) in the Pharmaceuticals Major industry. This means that HAWPF’s stock grew somewhat faster than BMY’s over the last 12 months.

HAWPF's SMR Rating (100) in the null industry is in the same range as BMY (100) in the Pharmaceuticals Major industry. This means that HAWPF’s stock grew similarly to BMY’s over the last 12 months.

HAWPF's Price Growth Rating (43) in the null industry is in the same range as BMY (60) in the Pharmaceuticals Major industry. This means that HAWPF’s stock grew similarly to BMY’s over the last 12 months.

HAWPF's P/E Growth Rating (100) in the null industry is in the same range as BMY (100) in the Pharmaceuticals Major industry. This means that HAWPF’s stock grew similarly to BMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYHAWPF
RSI
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
13%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
27%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
18%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
28%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
30%
Advances
ODDS (%)
Bullish Trend 3 days ago
53%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
54%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
42%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAWPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IGM118.931.44
+1.23%
iShares Expanded Tech Sector ETF
ACLO50.44N/A
N/A
TCW AAA CLO ETF
EZBC64.81-0.09
-0.14%
Franklin Bitcoin ETF
CIK2.95-0.01
-0.34%
Credit Suisse Asset Management Income Fund
UTSL40.20-0.90
-2.19%
Direxion Daily Utilities Bull 3X ETF

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with PFE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
-1.57%
PFE - BMY
53%
Loosely correlated
-1.87%
GILD - BMY
47%
Loosely correlated
-1.19%
MRK - BMY
46%
Loosely correlated
-1.02%
AMGN - BMY
45%
Loosely correlated
-0.82%
JNJ - BMY
42%
Loosely correlated
-0.76%
More

HAWPF and

Correlation & Price change

A.I.dvisor tells us that HAWPF and CSWYF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HAWPF and CSWYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAWPF
1D Price
Change %
HAWPF100%
N/A
CSWYF - HAWPF
27%
Poorly correlated
N/A
RHHVF - HAWPF
21%
Poorly correlated
-1.80%
BMY - HAWPF
20%
Poorly correlated
-1.57%
GLAXF - HAWPF
8%
Poorly correlated
N/A
OPHLY - HAWPF
8%
Poorly correlated
+2.77%
More